Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Micafungin Sodium.

Client Email

Product

Micafungin Sodium
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Micafungin Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 13 USDMF, 5 JDMF, 3 EU WC, 1 KDMF, 11 NDC API, 21 Listed Suppliers, $ API Reference Price

32 API Suppliers
13 USDMF
5 JDMF
3 EU WC
1 KDMF
11 NDC API
21 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

55 FDF Dossiers, 26 FDA Orange Book, 8 Europe, 4 Canada, 6 South Africa, 11 Listed Dossiers

55 FDF Dossiers
26 FDA Orange Book
8 Europe
4 Canada
6 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - EQ 100MG BASE/VIAL, INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL, SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 150MG BASE/150ML (EQ 1MG BASE/ML), SOLUTION;INTRAVENOUS - EQ 50MG BASE/50ML (EQ 1MG BASE/ML)

INJECTABLE;INTRAVENOUS - EQ 100MG BASE/VIAL
INJECTABLE;INTRAVENOUS - EQ 50MG BASE/VIAL
SOLUTION;INTRAVENOUS - EQ 100MG BASE/100ML (EQ 1MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 150MG BASE/150ML (EQ 1MG BASE/ML)
SOLUTION;INTRAVENOUS - EQ 50MG BASE/50ML (EQ 1MG BASE/ML)

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 17 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 6 Finished Drug Prices, 8 Annual Reports

2 US Medicaid Prescriptions
6 Finished Drug Prices
8 Annual Reports

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

$ API Ref.Price (USD/KG) : 103,536 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Astellas Pharma Canada Inc.

filter Patent Reset all filters

7 All

01 22044746

02 32202058

03 22341568

filter Product Reset all filters

7 All

01 7Micafungin Sodium

filter Dosage Reset all filters

7 All

01 5Lyophilized Powder for Injection

02 2Lyophilized powder for injection

filter Exp Date Reset all filters

7 All

01 22011-06-17

02 32015-09-29

03 22020-06-29

Product Main Page

01

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Brand Name : MYCAMINE

Patent Number : 2202058

Filing Date : 1995-09-29

Strength per Unit : 25mg

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Brand Name : MYCAMINE

Patent Number : 2202058

Filing Date : 1995-09-29

Strength per Unit : 50mg

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Brand Name : MYCAMINE

Patent Number : 2202058

Filing Date : 1995-09-29

Strength per Unit : 100 mg

Dosage Form : Lyophilized powder for injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2015-09-29

Date Granted : 2007-11-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-06-17

Date Granted : 2001-08-07

Brand Name : MYCAMINE

Patent Number : 2044746

Filing Date : 1991-06-17

Strength per Unit : 25mg

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2011-06-17

Date Granted : 2001-08-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-06-17

Date Granted : 2001-08-07

Brand Name : MYCAMINE

Patent Number : 2044746

Filing Date : 1991-06-17

Strength per Unit : 50mg

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2011-06-17

Date Granted : 2001-08-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-29

Date Granted : 2011-10-25

Brand Name : MYCAMINE

Patent Number : 2341568

Filing Date : 2000-06-29

Strength per Unit : 50mg

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2020-06-29

Date Granted : 2011-10-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Astellas Pharma Canada Inc.

Micafungin

Luxepack

Not Confirmed

Astellas Pharma Canada Inc.

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2020-06-29

Date Granted : 2011-10-25

Brand Name : MYCAMINE

Patent Number : 2341568

Filing Date : 2000-06-29

Strength per Unit : 100 mg

Dosage Form : Lyophilized powder for injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2020-06-29

Date Granted : 2011-10-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?